FindTrial
Sign In

Fentanyl as additive to Bupivacaine heavy for spinal Anaesthesia in pregnant female with severe form of pregnancy induced hypertension undergoing cesarean delivery and study of effects on Hemodynamics.

Comparasion of Intrathecal Fentanyl as an adjuvant to Hyperbaric Bupivacaine vs only hyperbaric Bupivacaine for Cesarean delivery in Pre-Eclampsia and Eclampsia patients : Effects on Hemodynamic stability. - Fentanyl and Bupivacaine Vs only Bupivacaine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113805
Enrollment
100
Registered
2026-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Fentanyl + Bupivacaine: Patients will receive intervention with 10-12mcg Hyperbaric Bupivacaine + 25mcg fentanyl intrathecally Control Intervention1: Only Bupivacaine: Patients will rec

Sponsors

Rajiv Gandhi Institute of Medical SciencesRIMS Hospital operation theatre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant females with Pre-eclampsia and eclampsia posted for elective cesarean section, gestational age greater than 34 weeks, Injuction MgSO4 given

Exclusion criteria

Exclusion criteria: Low platele count,INR more than 1.4, severe uncontrolled hypertension, feral distress requiring immediate delivery, refractory hypertension, HELLP syndrome with severe thrombocytopenia

Design outcomes

Primary

MeasureTime frame
Maternal Hemodynamics, incidence of Intra operative and post operative seizures, peri operative vasopressor requirement, Neonatal outcome APGARTimepoint: Intra operative period and post operative period upto 24 hours—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactBelli Yashaswi

Rajiv Gandhi Institute of Medical Sciences, Adilabad

yashaswini.belli@gmail.com7382945043

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026